135 related articles for article (PubMed ID: 37924925)
1. Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease.
Liu X; Liu X; Liu Y; Yang B; Li Y; Li F; Qian K; Zu J; Zhang W; Zhou S; Zhang T; Liu J; Cui G; Xu C
Brain Res; 2024 Jan; 1822():148660. PubMed ID: 37924925
[TBL] [Abstract][Full Text] [Related]
2. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
4. Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease.
Yin P; Niu X; Guan C; Zhang Z; Liu Y; Li J; Cui G; Zan K; Xu C
Psychogeriatrics; 2024 Mar; 24(2):415-425. PubMed ID: 38339819
[TBL] [Abstract][Full Text] [Related]
5. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson's disease in the MARK-PD study.
Pötter-Nerger M; Dutke J; Lezius S; Buhmann C; Schulz R; Gerloff C; Kuhle J; Choe CU
J Neural Transm (Vienna); 2022 Mar; 129(3):295-300. PubMed ID: 35072765
[TBL] [Abstract][Full Text] [Related]
7. Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease.
Li Y; Li F; Liu X; Zu J; Zhang W; Zhou S; Zhu J; Zhang T; Cui G; Xu C
Neurosci Lett; 2023 Aug; 812():137394. PubMed ID: 37437874
[TBL] [Abstract][Full Text] [Related]
8. Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson's disease.
Lv L; Zhang H; Tan X; Long Z; Qin L; Bai R; Xiao Q; Wu Z; Hu S; Tan C; Liao H; Yan W; Tang B; Ren F; Wang C
J Neurol; 2022 Dec; 269(12):6452-6466. PubMed ID: 35933494
[TBL] [Abstract][Full Text] [Related]
9. Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study.
Lin J; Ou R; Li C; Hou Y; Zhang L; Wei Q; Pang D; Liu K; Jiang Q; Yang T; Xiao Y; Zhao B; Chen X; Song W; Yang J; Wu Y; Shang H
BMC Med; 2023 Nov; 21(1):420. PubMed ID: 37932720
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and related factors of freezing of gait in patients with Parkinson's disease.
Zhang F; Shi J; Duan Y; Cheng J; Li H; Xuan T; Lv Y; Wang P; Li H
Brain Behav; 2021 Nov; 11(11):e2359. PubMed ID: 34551452
[TBL] [Abstract][Full Text] [Related]
12. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
[TBL] [Abstract][Full Text] [Related]
13. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
[TBL] [Abstract][Full Text] [Related]
14. The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype.
Santos-García D; de Deus-Fonticoba T; Suárez Castro E; M Aneiros Díaz Á; Feal-Painceiras MJ; Paz-González JM; García-Sancho C; Jesús S; Mir P; Planellas L; García-Caldentey J; Caballol N; Legarda I; Hernández-Vara J; González-Aramburu I; Ávila-Rivera MA; Catalán MJ; Nogueira V; Álvarez-Sauco M; Vela L; Escalante S; Cubo E; Sánchez-Alonso P; Alonso-Losada MG; López-Ariztegui N; Martinez-Martin P;
Neurol Sci; 2020 Oct; 41(10):2883-2892. PubMed ID: 32333181
[TBL] [Abstract][Full Text] [Related]
15. Repetitive Motor Control Deficits Most Consistent Predictors of Conversion to Freezing of Gait in Parkinson's Disease: A Prospective Cohort Study.
D'Cruz N; Vervoort G; Fieuws S; Moreau C; Vandenberghe W; Nieuwboer A
J Parkinsons Dis; 2020; 10(2):559-571. PubMed ID: 32039860
[TBL] [Abstract][Full Text] [Related]
16. A 12-year population-based study of freezing of gait in Parkinson's disease.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
[TBL] [Abstract][Full Text] [Related]
17. Brain activity during lower limb movements in Parkinson's disease patients with and without freezing of gait.
Piramide N; Agosta F; Sarasso E; Canu E; Volontè MA; Filippi M
J Neurol; 2020 Apr; 267(4):1116-1126. PubMed ID: 31897599
[TBL] [Abstract][Full Text] [Related]
18. Predicting the onset of freezing of gait in Parkinson's disease.
Wang F; Pan Y; Zhang M; Hu K
BMC Neurol; 2022 Jun; 22(1):213. PubMed ID: 35672669
[TBL] [Abstract][Full Text] [Related]
19. Association of freezing of gait and clinical features in patients with Parkinson's disease.
Aktürk T; Güven H; Güven B; Çomoğlu S
Acta Neurol Belg; 2021 Feb; 121(1):153-159. PubMed ID: 31654392
[TBL] [Abstract][Full Text] [Related]
20. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
